These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 18437077)

  • 41. [Profiles of low-molecular proteome spectrum obtained through SELDI-TOF mass spectrometry in the sera of patients with metastatic malignant melanoma: pilot study].
    Lakomý R'; Greplová K; Pilný R; Budinská E; Valík D; Poprach A; Nemecek R; Vyzula R
    Klin Onkol; 2009; 22(5):228-32. PubMed ID: 19886361
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Proteomic studies of early-stage and advanced ovarian cancer patients.
    Wang J; Zhang X; Ge X; Guo H; Xiong G; Zhu Y
    Gynecol Oncol; 2008 Oct; 111(1):111-9. PubMed ID: 18703221
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Looking for Thom's biomarkers with proteomics.
    Drukier AK; Grigoriev I; Brown LR; Tomaszewski JE; Sainsbury R; Godovac-Zimmermann J
    J Proteome Res; 2006 Aug; 5(8):2046-8. PubMed ID: 16889429
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Biomarker discovery in low-grade breast cancer using isobaric stable isotope tags and two-dimensional liquid chromatography-tandem mass spectrometry (iTRAQ-2DLC-MS/MS) based quantitative proteomic analysis.
    Bouchal P; Roumeliotis T; Hrstka R; Nenutil R; Vojtesek B; Garbis SD
    J Proteome Res; 2009 Jan; 8(1):362-73. PubMed ID: 19053527
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Epigenetic changes of pituitary tumor-derived transforming gene 1 in pancreatic cancer.
    Zhang ML; Lu S; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2008 Jun; 7(3):313-7. PubMed ID: 18522889
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical proteomics: current techniques and potential applications in the elderly.
    Siwy J; Vlahou A; Zimmerli LU; Zürbig P; Schiffer E
    Maturitas; 2011 Mar; 68(3):233-44. PubMed ID: 21112166
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Proteomics: unraveling the complexity of heart disease and striving to change cardiology.
    Van Eyk JE
    Curr Opin Mol Ther; 2001 Dec; 3(6):546-53. PubMed ID: 11804269
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Body fluid proteomics for biomarker discovery: lessons from the past hold the key to success in the future.
    Good DM; Thongboonkerd V; Novak J; Bascands JL; Schanstra JP; Coon JJ; Dominiczak A; Mischak H
    J Proteome Res; 2007 Dec; 6(12):4549-55. PubMed ID: 17970587
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Application of proteomics in cardiovascular medicine.
    Lam L; Lind J; Semsarian C
    Int J Cardiol; 2006 Mar; 108(1):12-9. PubMed ID: 16466817
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Avian proteomics: advances, challenges and new technologies.
    Doherty MK; McLean L; Beynon RJ
    Cytogenet Genome Res; 2007; 117(1-4):358-69. PubMed ID: 17675879
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The pancreatic cancer proteome - recent advances and future promise.
    Aspinall-O'Dea M; Costello E
    Proteomics Clin Appl; 2007 Sep; 1(9):1066-79. PubMed ID: 21136758
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Translational Research and Plasma Proteomic in Cancer.
    Santini AC; Giovane G; Auletta A; Di Carlo A; Fiorelli A; Cito L; Astarita C; Giordano A; Alfano R; Feola A; Di Domenico M
    J Cell Biochem; 2016 Apr; 117(4):828-35. PubMed ID: 26479787
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Deciphering protein molecular signatures in cancer tissues to aid in diagnosis, prognosis, and therapy.
    Caprioli RM
    Cancer Res; 2005 Dec; 65(23):10642-5. PubMed ID: 16322204
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Proteomics in asthma.
    Osei-Kumah A; Hodyl N; Clifton VL
    Expert Rev Clin Immunol; 2008 Nov; 4(6):713-21. PubMed ID: 20477121
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Proteomics analysis of bodily fluids in pancreatic cancer.
    Pan S; Brentnall TA; Chen R
    Proteomics; 2015 Aug; 15(15):2705-15. PubMed ID: 25780901
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Application of fluorescence dye saturation labeling for differential proteome analysis of 1,000 microdissected cells from pancreatic ductal adenocarcinoma precursor lesions.
    Sitek B; Sipos B; Klöppel G; Schmiegel W; Hahn SA; Meyer HE; Stühler K
    Methods Mol Biol; 2008; 425():1-14. PubMed ID: 18369882
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High-resolution biomarker discovery: Moving from large-scale proteome profiling to quantitative validation of lead candidates.
    Hewel JA; Emili A
    Proteomics Clin Appl; 2008 Oct; 2(10-11):1422-34. PubMed ID: 21136791
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Proteomics in hypertension.
    Carty DM; Schiffer E; Delles C
    J Hum Hypertens; 2013 Apr; 27(4):211-6. PubMed ID: 22874797
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Proteome-based biomarkers in pancreatic cancer.
    Sun C; Rosendahl AH; Ansari D; Andersson R
    World J Gastroenterol; 2011 Nov; 17(44):4845-52. PubMed ID: 22171124
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Target discovery and validation in pancreatic cancer.
    Beaty RM; Gronborg M; Pollack JR; Maitra A
    Methods Mol Biol; 2007; 360():57-89. PubMed ID: 17172725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.